- Title
- Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study (vol 22, pg 85, 2021)
- Creators - without role
- A. R. TanS-A ImA. Mattar
- Publication Details
- The lancet oncology, Vol.22(2), pp.E42-E42
- Publisher
- Elsevier
- Number of pages
- 1
- Identifiers
- 9939072208331
- Academic Unit
- King Abdulaziz University
- Language
- English
- Resource Type
- Journal article
Journal article
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study (vol 22, pg 85, 2021)
The lancet oncology, Vol.22(2), pp.E42-E42
01/02/2021
Metrics
1 Record Views